A severe clinical issue is an increase in the prevalence of infertility on a global scale. Worldwide, there are over 48 million infertile couples. Infertility caused by the male factor accounts for 20% to 30% of all cases. A typical morphology, decreased sperm concentration and poor sperm motility are just a few instances of the causes that could be to blame. The use of medications, hormone therapy and ART has increased along with knowledge of male infertility because of this. Some of the main causes of male infertility are alcohol consumption, smoking, obesity, stress, and lifestyle modifications. The National Center for Health Statistics reports a 15% global decline in the fertility rate for males under 30 between 2006 and 2017. These are the certain factors which propel the market growth.
According to Data Bridge Market Research the Infertility Testing Market is expected to grow with a CAGR of 3.2% in the forecast period of 2022 to 2029.
“Technical Developments Will Aid the Market Growth”
A major increase in computer-assisted semen analysis is anticipated in the upcoming years as a result of technical improvements. The most frequently used test for diagnosis is the analysis of the semen, which can be done using microscopic examination methods. For instance, Sandstone Diagnostics launched the Trak Volume Cup, a tool that enables men to measure semen volume and detect hypospermia at home, in April 2018 after receiving FDA approval in the United States.
What restraints the growth of Infertility Testing Market?
“High Cost of Infertility Testing Are Expected to Hamper the Market's Growth”
The market's expansion is being restrained by the high cost, the societal stigma around infertility and danger involved with therapies. The majority of people are discouraged from seeking infertility therapy due to its exorbitant cost. Additionally, the market for infertility testing and treatments has difficulties as a whole due to the lack of a 100% guarantee of the treatment's success.
Segmentation: Infertility Testing Market
The infertility testing market is segmented on the basis of type, test kits, prescription mode, distribution channel and end-user.
- The infertility testing market is segmented on the basis of type into female infertility testing and male infertility testing.
- On the basis of test kits, the infertility testing market is segmented into follicular stimulating hormone (FSH) urine test kits, luteinizing hormone (LH) urine test kits, human chorionic gonadotropin (HCG) hormone blood test kits and others.
- On the basis of prescription mode, the infertility testing market is segmented into prescription based and over the counter (OTC) based.
- On the basis of distribution channel, the infertility testing market is segmented into hospitals pharmacies, online pharmacies, pharmacies and drug stores.
- On the basis of end-user, the infertility testing market is segmented into fertility centers, hospitals and clinics, research institutes, and cryobanks.
Regional Insights: North America is expected to dominate the Infertility Testing Market
North America is expected to dominate the market due to the presence of significant key factors, as well as the area's advanced healthcare system and high standard of living, IVF treatment funds, widespread use and increased infertility rates among American women.
- In addition, the Asia-Pacific region is likely to register highest growth rate during the forecast period of 2022 to 2029 due to increased government backing, R&D activity and investments in the healthcare industry, increasing lifestyle changes, efforts by policymakers to incorporate IVF in insurance plans, and the appearance of leading cryobanking firms operating in the Indian market.
To know more about the study visit, https://www.databridgemarketresearch.com/fr/reports/global-infertility-testing-market
Recent Developments in Infertility Testing Market
- In 2019, The National Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA), Government of India, awarded Cadila Pharmaceuticals the Good Laboratory Practices Certification for its Dholka facility. With the certification, the business is now a GLP-compliant facility and its research efforts will be acknowledged in all OECD members.
The Prominent Key Players Operating in the Infertility Testing Market Include:
- AB Scientific Ltd. (U.S.)
- Art Biotech Pvt. Ltd. (India)
- Cook (U.S.)
- Dxnow, Inc. (U.S.)
- Eppendorf SE (U.S.)
- Esco Micro Pte. Ltd. (Singapore)
- Hamilton Thorne, Ltd. (U.S.)
- LabIVF Asia Pte Ltd. (Singapore)
- Rocket Medical plc (U.K.)
- The Cooper Companies, Inc. (U.S.)
- Vitrolife (Sweden)
- Irvine Scientific (U.S.)
- Microptic (U.S.)
- The Cooper Companies Inc. (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of Infertility testing market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Infertility Testing Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
